As such, the current data on small molecules interfering with Sema3D signaling has only demonstrated that continuous endeavor in discovering Sema3D inhibitors for dementia treatment is worthwhile, although we did not explore Sema3D co-receptors because this was beyond the scope of the present work. Here, SEMA3D is linked to dementia.